A discussion on how market volatility creates opportunity for collaborative multi-asset teams and where we are finding value in equity and fixed income today.
Insights
Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.
Assessing the potential impact of President Trump’s “most favored nation” drug pricing policy on biopharma companies.
With large capital reserves, an improving regulatory backdrop, and positive growth trends, many financial firms look prepared to withstand a potential recession.
Why we favor quality over speculative growth in today’s uncertain environment.
These company characteristics could help investors win out over looming tariffs and federal funding cuts in the healthcare sector.
Is ESG dead? Far from it – but misconceptions abound.
Defensive stocks have outperformed, but cyclicals still offer higher growth potential.
The exciting long-term investment potential of China's humanoid robots.
Uncertainty about the outlook for AI spending and trade have made focusing on corporate fundamentals all the more important.
Questions that are top of mind for investors moving into the next phase of the AI wave.
Key considerations for property equities investors amid the current market turmoil.